SWK Holdings Corporation to Participate in A.G.P.'s Virtual Healthcare Symposium
SWK Holdings Corporation (Nasdaq: SWKH) announced that its CEO, Winston Black, will participate in A.G.P.'s Virtual Healthcare Symposium on November 19, 2020. The CEO will engage in one-on-one meetings with investors to discuss the company's business strategies and recent achievements. Registered investors can request a meeting time. SWK Holdings specializes in financing for the healthcare sector, partnering with product marketers to offer flexible funding solutions, while also owning Enteris Biopharma, enhancing its portfolio through innovative drug delivery technologies.
- None.
- None.
DALLAS, Nov. 11, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Black, will participate in A.G.P.'s Virtual Healthcare Symposium on Thursday, November 19, 2020.
Mr. Black will host virtual one-on-one meetings with investors to discuss SWK Holdings' business and investment strategy, recent corporate and portfolio company achievements. Investors registered to attend the conference are invited to request meeting times.
For questions and inquiries regarding the conference or to register for a one-on-one meeting, please contact a registered A.G.P. representative or email A.G.P. Events at AGPEVENTS@ALLIANCEG.COM.
About SWK Holdings:
SWK Holdings Corporation is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK's business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. SWK also owns Enteris Biopharma, whose core Peptelligence™ drug delivery technology creates oral formulations of peptide-based and BCS class II, III, and IV small molecules. With Enteris, SWK has the opportunity to grow its specialty finance business by actively building a wholly-owned portfolio of milestones and royalties through licensing activities. Additional information on the life science finance market is available on the Company's website at www.swkhold.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
View original content:http://www.prnewswire.com/news-releases/swk-holdings-corporation-to-participate-in-agps-virtual-healthcare-symposium-301170670.html
SOURCE SWK Holdings Corporation
FAQ
When will SWK Holdings participate in A.G.P.'s Virtual Healthcare Symposium?
Who is the CEO of SWK Holdings Corporation?
What will Winston Black discuss during the symposium?
How can investors schedule a meeting with SWK Holdings at the symposium?
What does SWK Holdings Corporation focus on?
Does SWK Holdings own any other companies?
